RNAi-Inducing Lentiviral Vectors for Anti-HIV-1 Gene Therapy

Methods in Molecular Biology

Volumn 721, Issue , 2011, Pages 293-311

  Liu, Ying Poi ^a   Westerink, Jan Tinus ^b   ter Brake, Olivier ^b   Berkhout, Ben ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b NONE

Author keywords

Antiviral; Gene therapy; HIV 1; Lentiviral vector; miRNA; RNAi; shRNA; siRNA; Titer; Transduction

Indexed keywords

MICRORNA; SMALL INTERFERING RNA;

ARTICLE; GENE THERAPY; GENE VECTOR; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METHODOLOGY; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; RNA INTERFERENCE;

BASE SEQUENCE; GENE THERAPY; GENETIC VECTORS; HIV INFECTIONS; HIV-1; HUMANS; MICRORNAS; MOLECULAR SEQUENCE DATA; RNA INTERFERENCE; RNA, SMALL INTERFERING;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS;

EID: 79960047585     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61779-037-9_18     Document Type: Chapter

References (66)

1. Waterhouse, P. M., Wang, M. B., Lough, T. (2001) Gene silencing as an adaptive defence against viruses. Nature 411, 834–42.
2. Voinnet, O. (2001) RNA silencing as a plant immune system against viruses. Trends Genet 17, 449–59.
3. Wilkins, C., Dishongh, R., Moore, S. C., Whitt, M. A., Chow, M., Machaca, K. (2005) RNA interference is an antiviral defence mechanism in Caenorhabditis elegans. Nature 436, 1044–7.
4. Wang, X. H., Aliyari, R., Li, W. X. et al. (2006) RNA interference directs innate immunity against viruses in adult Drosophila. Science 312, 452–4.
5. Segers, G. C., Zhang, X., Deng, F., Sun, Q., Nuss, D. L. (2007) Evidence that RNA silencing functions as an antiviral defense mechanism in fungi. Proc Natl Acad Sci U S A 104, 12902–6.
6. Bernstein, E., Caudy, A. A., Hammond, S. M., Hannon, G. J. (2001) Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409, 363–6.
7. Yi, R., Qin, Y., Macara, I. G., Cullen, B. R. (2003) Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev 17, 3011–6.
8. Lund, E., Guttinger, S., Calado, A., Dahlberg, J. E., Kutay, U. (2004) Nuclear export of microRNA precursors. Science 303, 95–8.
9. Bartel, D. P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281–97.
10. Filipowicz, W. (2005) RNAi: the nuts and bolts of the RISC machine. Cell 122, 17–20.
11. Haasnoot, J., Westerhout, E. M., Berkhout, B. (2007) RNA interference against viruses: strike and counterstrike. Nat Biotechnol 25, 1435–43.
12. Haasnoot, P. C. J., Berkhout, B. (2006) RNA interference: Its use as antiviral therapy. Handbook of Experimental Pharmacology. Heidelberg: Springer, 117–50.
13. Kim, D. H., Rossi, J. J. (2007) Strategies for silencing human disease using RNA interference. Nat Rev Genet 8, 173–84.
14. Paddison, P. J., Caudy, A. A., Bernstein, E., Hannon, G. J., Conklin, D. S. (2002) Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev 16, 948–58.
15. Brummelkamp, T. R., Bernards, R., Agami, R. (2002) A system for stable expression of short interfering RNAs in mammalian cells. Science 296, 550–3.
16. Zeng, Y., Yi, R., Cullen, B. R. (2003) MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proc Natl Acad Sci U S A 100, 9779–84.
17. Ter Brake, O., Konstantinova, P., Ceylan, M., Berkhout, B. (2006) Silencing of HIV-1 with RNA interference: a multiple shRNA approach. Mol Ther 14, 883–92.
18. Ter Brake, O., ‘t Hooft, K., Liu, Y. P., Centlivre, M., von Eije, K. J., Berkhout, B. (2008) Lentiviral vector design for multiple shRNA expression and durable HIV-1 inhibition. Mol Ther 16, 557–64.
19. Liu, Y. P., Haasnoot, J., Berkhout, B. (2007) Design of extended short hairpin RNAs for HIV-1 inhibition. Nucleic Acids Res 35, 5683–93.
20. Liu, Y. P., Haasnoot, J., Ter Brake, O., Berkhout, B., Konstantinova, P. (2008) Inhibition of HIV-1 by multiple siRNAs expressed from a single microRNA polycis-tron. Nucleic Acids Res 36, 2811–24.
21. Liu, Y. P., von Eije, K. J., Schopman, N. C. et al. (2009) Combinatorial RNAi against HIV-1 using extended short hairpin RNAs. Mol Ther 17, 1712–23.
22. Liu, Y. P., Gruber, J., Haasnoot, J., Konstantinova, P., Berkhout, B. (2009) RNAi-mediated inhibition of HIV-1 by targeting partially complementary viral sequences. Nucleic Acids Res 37, 6194–204.
23. Banerjea, A., Li, M. J., Bauer, G. et al. (2003) Inhibition of HIV-1 by lentiviral vector-transduced siRNAs in T lymphocytes differentiated in SCID-hu mice and CD34+ progenitor cell-derived macrophages. Mol Ther 8, 62–71.
24. Boden, D., Pusch, O., Lee, F., Tucker, L., Ramratnam, B. (2004) Efficient gene transfer of HIV-1-specific short hairpin RNA into human lymphocytic cells using recombinant adeno-associated virus vectors. Mol Ther 9, 396–402.
25. Das, A. T., Brummelkamp, T. R., Westerhout, E. M. et al. (2004) Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition. J Virol 78, 2601–5.
26. Lee, S. K., Dykxhoorn, D. M., Kumar, P. et al. (2005) Lentiviral delivery of short hairpin RNAs protects CD4 T cells from multiple clades and primary isolates of HIV. Blood 106, 818–26.
27. Boden, D., Pusch, O., Silbermann, R., Lee, F., Tucker, L., Ramratnam, B. (2004) Enhanced gene silencing of HIV-1 specific siRNA using microRNA designed hairpins. Nucleic Acids Res 32, 1154–8.
28. Boden, D., Pusch, O., Lee, F., Tucker, L., Ramratnam, B. (2003) Human immunodeficiency virus type 1 escape from RNA interference. J Virol 77, 11531–5.
29. Westerhout, E. M., Ooms, M., Vink, M., Das, A. T., Berkhout, B. (2005) HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. Nucleic Acids Res 33, 796–804.
30. Harper, S. Q., Staber, P. D., He, X. et al. (2005) RNA interference improves motor and neuropathological abnormalities in a Huntington’s disease mouse model. Proc Natl Acad Sci U S A 102, 5820–5.
31. Ralph, G. S., Radcliffe, P. A., Day, D. M. et al. (2005) Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model. Nat Med 11, 429–33.
32. Gimeno, R., Weijer, K., Voordouw, A. et al. (2004) Monitoring the effect of gene silencing by RNA interference in human CD34+ cells injected into newborn RAG2-/-gammac-/-mice: functional inactivation of p53 in developing T cells. Blood 104, 3886–93.
33. Van den Haute, C., Eggermont, K., Nuttin, B., Debyser, Z., Baekelandt, V. (2003) Lentiviral vector-mediated delivery of short hairpin RNA results in persistent knockdown of gene expression in mouse brain. Hum Gene Ther 14, 1799–807.
34. Greber, U. F., Fassati, A. (2003) Nuclear import of viral DNA genomes. Traffic 4, 136–43.
35. Follenzi, A., Battaglia, M., Lombardo, A., Annoni, A., Roncarolo, M. G., Naldini, L. (2004) Targeting lentiviral vector expression to hepatocytes limits transgene-specific immune response and establishes long-term expression of human antihemophilic factor IX in mice. Blood 103, 3700–9.
36. Kordower, J. H., Emborg, M. E., Bloch, J. et al. (2000) Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson’s disease. Science 290, 767–73.
37. Miyoshi, H., Smith, K. A., Mosier, D. E., Verma, I. M., Torbett, B. E. (1999) Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science 283, 682–6.
38. Naldini, L., Blomer, U., Gallay, P. et al. (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263–7.
39. Nguyen, T. H., Oberholzer, J., Birraux, J., Majno, P., Morel, P., Trono, D. (2002) Highly efficient lentiviral vector-mediated transduction of nondividing, fully reimplantable primary hepatocytes. Mol Ther 6, 199–209.
40. Kafri, T., Blomer, U., Peterson, D. A., Gage, F. H., Verma, I. M. (1997) Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat Genet 17, 314–7.
41. Laufs, S., Guenechea, G., Gonzalez-Murillo, A. et al. (2006) Lentiviral vector integration sites in human NOD/SCID repopulating cells. J Gene Med 8, 1197–207.
42. Montini, E., Cesana, D., Schmidt, M. et al. (2006) Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration. Nat Biotechnol 24, 687–96.
43. Montini, E., Cesana, D., Schmidt, M. et al. (2009) The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy. J Clin Invest 119, 964–75.
44. Cartier, N., Hacein-Bey-Abina, S., Bartholomae, C. C. et al. (2009) Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 326, 818–23.
45. Anderson, J., Li, M. J., Palmer, B. et al. (2007) Safety and efficacy of a lentiviral vector containing three anti-HIV genes – CCR5 ribozyme, tat-rev siRNA, and TAR decoy – in SCID-hu mouse-derived T cells. Mol Ther 15, 1182–8.
46. Henry, S. D., van der, W. P., Metselaar, H. J., Tilanus, H. W., Scholte, B. J., van der Laan, L. J. (2006) Simultaneous targeting of HCV replication and viral binding with a single lentiviral vector containing multiple RNA interference expression cassettes. Mol Ther 14, 485–93.
47. Poluri, A., Sutton, R. E. (2007) Titers of HIV-based vectors encoding shRNAs are reduced by a Dicer-dependent mechanism. Mol Ther 16, 378–86.
48. Ter Brake, O., Berkhout, B. (2007) Lentiviral vectors that carry anti-HIV shRNAs: problems and solutions. J Gene Med 9, 743–50.
49. Zhou, D., Zhang, J., Wang, C. et al. (2009) A method for detecting and preventing negative RNA interference in preparation of lentiviral vectors for siRNA delivery. RNA 15, 732–40.
50. Liu, Y. P., Vink, M. A., Westerink, J. T. et al. (2010) Titers of lentiviral vectors encoding shRNAs and miRNAs are reduced by different mechanisms that require distinct repair strategies. RNA 16, 1328–39.
51. Tafer, H., Ameres, S. L., Obernosterer, G. et al. (2008) The impact of target site accessibility on the design of effective siRNAs. Nat Biotechnol 26, 578–83.
52. Obernosterer, G., Tafer, H., Martinez, J. (2008) Target site effects in the RNA interference and microRNA pathways. Biochem Soc Trans 36, 1216–9.
53. Ameres, S. L., Martinez, J., Schroeder, R. (2007) Molecular basis for target RNA recognition and cleavage by human RISC. Cell 130, 101–12.
54. Brown, K. M., Chu, C. Y., Rana, T. M. (2005) Target accessibility dictates the potency of human RISC. Nat Struct Mol Biol 12, 469–70.
55. Seppen, J., Rijnberg, M., Cooreman, M. P., Oude Elferink, R. P. (2002) Lentiviral vectors for efficient transduction of isolated primary quiescent hepatocytes. J Hepatol 36, 459–65.
56. Kotsopoulou, E., Kim, V. N., Kingsman, A. J., Kingsman, S. M., Mitrophanous, K. A. (2000) A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene. J Virol 74, 4839–52.
57. Dull, T., Zufferey, R., Kelly, M. et al. (1998) A third-generation lentivirus vector with a conditional packaging system. J Virol 72, 8463–71.
58. Jeeninga, R. E., Hoogenkamp, M., Armand-Ugon, M., de Baar, M., Verhoef, K., Berkhout, B. (2000) Functional differences between the long terminal repeat transcriptional promoters of HIV-1 subtypes A through G. J Virol 74, 3740–51.
59. Yu, J. Y., DeRuiter, S. L., Turner, D. L. (2002) RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc Natl Acad Sci U S A 99, 6047–52.
60. Koper-Emde, D., Herrmann, L., Sandrock, B., Benecke, B. J. (2004) RNA interference by small hairpin RNAs synthesised under control of the human 7S K RNA promoter. Biol Chem 385, 791–4.
61. Denti, M. A., Rosa, A., Sthandier, O., De Angelis, F. G., Bozzoni, I. (2004) A new vector, based on the PolII promoter of the U1 snRNA gene, for the expression of siRNAs in mammalian cells. Mol Ther 10, 191–9.
62. Haqqi, T., Zhao, X., Panciu, A., Yadav, S. P. (2002) Sequencing in the presence of betaine: improvement in sequencing of the localized repeat sequence regions. J Biomol Tech 13, 265–71.
63. Andersson, M. G., Haasnoot, P. C. J., Xu, N., Berenjian, S., Berkhout, B., Akusjarvi, G. (2005) Suppression of RNA interference by adenovirus virus-associated RNA. J Virol 79, 9556–65.
64. de Vries, W., Haasnoot, J., van der Velden, J. et al. (2008) Increased virus replication in mammalian cells by blocking intracellular innate defense responses. Gene Ther 15, 545–52.
65. Haasnoot, J., de Vries, W., Geutjes, E. J., Prins, M., de Haan, P., Berkhout, B. (2007) The Ebola virus VP35 protein is a suppressor of RNA silencing. PLoS Pathog 3, e86.
66. Popa, I., Harris, M. E., Donello, J. E., Hope, T. J. (2002) CRM1-dependent function of a cis-acting RNA export element. Mol Cell Biol 22, 2057–67.